Company Filing History:
Years Active: 2023
Title: Arnout Everaert: Innovator in Pharmaceutical Composition
Introduction
Arnout Everaert is a notable inventor based in Mariakerke, SE. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative dosage forms for peroral administration.
Latest Patents
Everaert holds a patent for a dry powder composition designed for peroral administration. This pharmaceutical dosage form comprises a particulate mixture that includes solid particles of N-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide (C21) or a pharmaceutically acceptable salt thereof. The composition is mixed with carrier particles that have similar weight- and/or volume-based mean diameters and is contained within a capsule suitable for gastrointestinal administration. This invention aims to treat lung diseases such as idiopathic pulmonary fibrosis, sarcoidosis, and respiratory virus-induced tissue damage.
Career Highlights
Everaert is currently associated with Vicore Pharma AB, where he continues to advance his research and development efforts in the pharmaceutical sector. His work focuses on creating effective treatments for serious respiratory conditions.
Collaborations
He collaborates with esteemed colleagues, including Ola Camber and Stefan Grudén, to enhance the impact of his innovations in the pharmaceutical industry.
Conclusion
Arnout Everaert's contributions to pharmaceutical innovations, particularly in the area of peroral dosage forms, highlight his commitment to improving treatment options for lung diseases. His work continues to pave the way for advancements in medical science.